MedTrace Logo

Diagnostic Performance and Prognostic Ability of the QFR

NCT04102917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 915

Last updated 2019-09-25

No results posted yet for this study

Summary

1. The primary technical endpoint was the diagnostic performance of the QFR against the FFR.
2. The primary clinical endpoint was target vessel failure (TVF) between two groups distributed by a QFR cut-off value of 0.8

Conditions

  • Ischemic Heart Disease

Interventions

DIAGNOSTIC_TEST

QFR assessment

The quantitative flow ratio (QFR) is a novel angiography-based method for noninvasive functional assessment of intermediate coronary lesions.

Sponsors & Collaborators

  • National Research Foundation of Korea

    collaborator OTHER

  • Seoul Saint Mary's Hospital

    collaborator UNKNOWN

  • Incheon Saint Mary's Hospital

    collaborator UNKNOWN

  • Seoul Saint Paul's Hospital

    collaborator UNKNOWN

  • Uijeongbu Saint Mary's Hospital

    collaborator UNKNOWN

  • Seoul St. Mary's Hospital

    lead OTHER

Principal Investigators

  • Kiyuk Chang, MD, PhD · Seoul Saint Mary's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2018-05-31
Completion
2019-06-14

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04102917 on ClinicalTrials.gov